NFE2L2 and familial pancreatic carcinoma: On the basis of our observations of the negative correlation between dCK and NRF2 expression and the decisive roles of NRF2 in pancreatic cancer oncogenesis and progression, we proposed that dCK might inhibit pancreatic cancer cell proliferation.